South Korea authorizes private sector use of state facilities for ASF vaccine production

The South Korean government will allow private firms to utilize Animal and Plant Quarantine Agency research facilities to accelerate African Swine Fever (ASF) vaccine development. This policy shift aims to overcome infrastructure bottlenecks in vaccine manufacturing, though the timeline for commercial availability remains uncertain.